IUHSA
FPRX

Itau Unibanco Holding S.A.’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-300
Closed -$3K – 851
2019
Q1 		$3K Hold
300
– – ﹤0.01% 585
2018
Q4 		$3K Sell
300
-298
-50% -$3.55K ﹤0.01% 585
2018
Q3 		$8K Sell
598
-19
-3% -$283 ﹤0.01% 583
2018
Q2 		$10K Buy
617
+1
+0.2% +$17 ﹤0.01% 703
2018
Q1 		$11K Buy
616
+444
+258% +$8.66K ﹤0.01% 556
2017
Q4 		$4K Buy
+172
New +$5.53K ﹤0.01% 536

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Itau Unibanco Holding S.A.'s FPRX Position: Q2 2019 in Review

Itau Unibanco Holding S.A. sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2019, closing a stake of 300 shares — an estimated $3K sold.

Itau Unibanco Holding S.A. first reported a position in FPRX in Q4 2017 and held it in 6 quarters. The position peaked at $11K in Q1 2018. 114 funds tracked by Wall St. Rank hold FPRX as of Q2 2019.

  • Itau Unibanco Holding S.A. reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 300 Five Prime Therapeutics, Inc. shares in Q2 2019, an estimated $3K.
  • Itau Unibanco Holding S.A. first reported a position in Five Prime Therapeutics, Inc. in Q4 2017 and held it in 6 quarters.
  • Itau Unibanco Holding S.A.'s Five Prime Therapeutics, Inc. position peaked at $11K in Q1 2018.
  • 114 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2019, filed 14 Aug 2019.